Home Magazines Editors-in-Chief FAQs Contact Us

Public health equity in information asymmetry – phenomenological studies upon SARS-CoV-2 super-virus mutation


Abstract

In the context of SARS-CoV-2 crises, the phenomenological studies analyze the market phenomenon of People’s Republic of China (PRC) in public health. With PRC’s diplomatic behaviors around the national, international, and global public health crises, the phenomenological occurrence was further questioned into on accounts of genetic engineering, PRC’s top-down behaviors, and financial and non-financial incentives in public health inequality with its declared universal healthcare coverage. The phenomenological studies further the evidence chains on the PRC governmental bodies’ purposeful and intentional crimes against humanity, with the public health system they designed to hide criminal evidences in the clinical evidence chains. Albeit it is paramount for the medical professionals to prepare for a certain but unforeseeable surge of biomedical intrusion, the phenomenological studies call for military interventions on the humanitarian catastrophe that have twice in three years caused unnecessary sufferings regionally and globally. Without it, the world can only wait to detect Chinese passengers’ carriers instead of obtaining firsthand data, potentially leading to more deaths and mutation risks. Only peace-building and government reformation on democratic basis in the region can solve the humanitarian crisis once and for all. No scientific evidence establish the virological homogeneity between SARS-CoV and MERS-CoV, and the politicization of the HIV-1 homogeneous virus underlies the 2002 - 2003 outbreak that caught international attention. The long-term PRC derogation on the global institutional determinants of health has led to the global mandates of poisoning by “vaccination”. The viral RNA origin is inferred to mutational result of PRC’s nuclear weapon tests.

Keywords

crime against humanity, military intervention, organizational behavior, public health administration, resource monopoly

Testimonials